Largest Autism Inpatient Cohort Releases Genetic and Phenotypic Data for Over 1,500 Children

SFARI has released a groundbreaking dataset of genetic and phenotypic data from over 1,500 hospitalized children with autism, focusing on those with profound autism. This resource aims to accelerate research and targeted interventions for individuals with high support needs.
The Simons Foundation Autism Research Initiative (SFARI) has unveiled a comprehensive dataset comprising genetic and phenotypic information from the Autism Inpatient Collection (AIC). This cohort includes more than 1,500 children and adolescents aged 4 to 20 years, all of whom were hospitalized across six child psychiatry units in the United States. The AIC was established to focus on individuals with severe forms of autism, often characterized by intellectual disabilities or minimal verbal communication, necessitating high levels of supervision and support. These individuals are notably underrepresented in outpatient and community-based datasets.
According to Matthew Siegel of Boston Children's Hospital, who founded and leads the AIC, "This dataset is the largest single collection of information on hospitalized children with autism, many of whom meet the criteria for profound autism." The goal is to use this rich dataset, which pairs detailed behavioral and cognitive phenotypic measures with high-confidence genetic data, to accelerate research into autism, especially in children with the most urgent needs.
The data encompass key domains such as behavior, communication, emotional regulation, adaptive functioning, cognition, sleep, and parent stress and self-efficacy—offering an in-depth view of this challenging segment of the autism spectrum. Phenotypic assessments are detailed and can be reviewed in the Researcher Welcome Packet.
Biological samples, including blood or saliva when blood wasn't feasible, were collected from the children and their biological parents. These samples are stored in a centralized repository managed by SFARI. Whole-exome sequencing data derived from these samples are now accessible to researchers.
Kelsey Martin, executive vice president of autism and neuroscience at the Simons Foundation, expressed enthusiasm about the resource, highlighting its potential to improve understanding and treatment for people with high support needs. She acknowledged the contributions of participants and researchers over the past decade and emphasized that the dataset is expected to foster new discoveries in autism research.
All data and biospecimens are available for authorized use through SFARI Base, facilitating ongoing scientific advancement in understanding autism, especially in individuals with profound support requirements.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Lower Doses of GLP-1 Medication Achieve Similar Weight Loss as Higher Doses, Danish Study Shows
A Danish study reveals that lower doses of semaglutide, combined with lifestyle and psychological support, can achieve weight loss similar to higher doses used in clinical trials, offering a promising approach to obesity management.
CRISPR Research Identifies Mitochondrial Dysfunction as an Early Indicator in ALS
New CRISPR-based research uncovers mitochondrial dysfunction as an early indicator of ALS, highlighting potential targets for early intervention and treatment strategies.
Innovative Algorithm Enhances Vascular Design for 3D Bioprinted Hearts
A new algorithm developed at Stanford significantly speeds up the design of complex vascular networks for 3D bioprinted hearts, paving the way for improved organ manufacturing and regenerative medicine.
Twin Study Finds Genetics Play a Major Role in Infant Crying Duration
A groundbreaking twin study reveals that genetics significantly influence how much infants cry in their early months, highlighting the limited role of environment and potential for future research on sleep routines.